Your browser doesn't support javascript.
loading
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
San-Miguel, Jesús F; Hungria, Vania T M; Yoon, Sung-Soo; Beksac, Meral; Dimopoulos, Meletios A; Elghandour, Ashraf; Jedrzejczak, Wieslaw W; Guenther, Andreas; Na Nakorn, Thanyaphong; Siritanaratkul, Noppadol; Schlossman, Robert L; Hou, Jian; Moreau, Philippe; Lonial, Sagar; Lee, Jae-Hoon; Einsele, Hermann; Salwender, Hans; Sopala, Monika; Redhu, Suman; Paul, Sofia; Corrado, Claudia; Richardson, Paul G.
Affiliation
  • San-Miguel JF; Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.
  • Hungria VTM; Santa Casa de Misericordia de São Paulo Hospital, São Paulo, Brazil.
  • Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Beksac M; Department of Haematology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
  • Elghandour A; Alexandria University, Alexandria, Egypt.
  • Jedrzejczak WW; Haematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Guenther A; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University Hospital Schleswig-Holstein and University of Kiel, Kiel, Germany.
  • Na Nakorn T; King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand.
  • Siritanaratkul N; Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Schlossman RL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Hou J; Department of Haematology, Shanghai Changzheng Hospital, Shanghai, China.
  • Moreau P; University Hospital of Nantes, Nantes, France.
  • Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Lee JH; Department of Internal Medicine, Gachon University Gil Hospital, Incheon, South Korea.
  • Einsele H; Medizinische Klinik and Poliklinik II, University of Würzburg, Würzburg, Germany.
  • Salwender H; Asklepios Klinik Altona, Hamburg, Germany.
  • Sopala M; Novartis Pharma AG, Basel, Switzerland.
  • Redhu S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Paul S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Corrado C; Novartis Pharma AG, Basel, Switzerland.
  • Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Br J Haematol ; 179(1): 66-74, 2017 10.
Article in En | MEDLINE | ID: mdl-28653400
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2017 Document type: Article Affiliation country: Country of publication: